<DOC>
	<DOCNO>NCT00757107</DOCNO>
	<brief_summary>This evaluation conduct evaluate safety performance two different stem lengths Taperloc Total Hip System . Per implant bone loss migration stem compare two group Dual-energy X-ray absorptiometry ( DEXA ) radiostereomektric analysis</brief_summary>
	<brief_title>Taperloc Versus Taplerloc Microplasty</brief_title>
	<detailed_description>Consecutive patient 50 - 70 year diagnose primary osteoarthritis hip eligible total hip arthroplasty ask participate study . Periprosthetic bone loss , migration component clinical score record prospectively 3,6,12 24 month .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Inclusion criterion : Patients primary osteoarthritis hip schedule THA . Suitable anatomy stem Willingness ability follow studyprotocol Exclusion Criteria Malignancy metastatic bone disease . Any disease severely affect bone mineral metabolism Ongoing previous treatment ( within 5 year prior inclusion ) steroid Ongoing previous treatment ( within 5 year prior inclusion ) antiresorptives . Ongoing previous treatment ( within 5 year prior inclusion ) immunosuppressive drug . Ongoing previous treatment ( within 5 year prior inclusion ) anticonvulsive therapy . Ongoing previous treatment ( within 5 year prior inclusion ) hormonal therapy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Short femoral stem</keyword>
	<keyword>Stress shield</keyword>
	<keyword>Stem migration</keyword>
	<keyword>Implant Survival</keyword>
	<keyword>DEXA</keyword>
	<keyword>Radiostereometric analysis</keyword>
</DOC>